Efficient T-cell receptor signaling requires a high-affinity interaction between the Gads C-SH3 domain and the SLP-76 RxxK motif
A quantitative biochemical study found that efficient T-cell receptor signaling depends primarily on the high-affinity interaction (KD = 8–20 nM) between the Gads C-SH3 domain and the SLP-76 RxxK motif rather than on the exceptional specificity of that interaction, since TCR signaling tolerated SLP-76 variants that crossreacted with dozens of other SH3 domains as long as high-affinity Gads binding was preserved, with the authors emphasizing that why such stringent specificity evolved in the first place remains an open question.
Dr. Monica Raina
Periodontist
Table of contents
Share
Background & context
Adaptor proteins assemble signaling pathways by linking activated receptors to downstream effectors through modular interaction domains — but because many of these domains can engage multiple potential partners, the same flexibility that allows signaling diversity also creates a risk of unwanted cross-talk between pathways. How a cell maintains fidelity of signal transmission in the face of this potential cross-reactivity has remained poorly understood.
In T-cell receptor (TCR) signaling, the adaptor protein Gads links the phosphorylated docking protein LAT to the scaffold SLP-76 through Gads’ C-terminal SH3 domain binding an unusual RxxK motif in SLP-76 — distinct from the proline-rich PxxP motifs that most SH3 domains recognize. This interaction is essential for normal T-cell development, yet it was unclear whether its biological importance rests primarily on unusually high binding affinity, exceptional specificity for the correct partner among many SH3 domains, or some combination of both — a gap that limited understanding of how affinity and specificity together govern signaling fidelity in a complex mammalian pathway.
How the question was resolved
Early structural work had already shown that Gads C-SH3 binds the SLP-76 RxxK motif through an atypical interface, but a structural snapshot alone could not establish which biochemical property — affinity, specificity, or both — actually determines whether TCR signaling succeeds or fails.
This study isolates and tests each property independently, then connects each one to a measurable cellular signaling output:
Affinity threshold | Specificity / selectivity | Functional consequence in cells |
|---|---|---|
Quantifying the Gads C-SH3/SLP-76 interaction by SPR and ITC (KD = 8–20 nM) and systematically weakening it via point mutations (KD ranging from 4 nM to 44 µM) | Probing 147 distinct SH3 domains with the SLP-76 RxxK peptide to show it binds only four — and engineering single point mutations that create deliberately crossreactive SLP-76 variants while holding affinity for Gads constant | Measuring TCR-induced NFAT activation and calcium flux in Jurkat T cells expressing each SLP-76 variant, revealing that signaling output tracks tightly with Gads-binding affinity but tolerates crossreactivity to other SH3 domains |
This approach moves beyond simply describing the Gads/SLP-76 interface, instead establishing a quantitative, causal link between a specific biophysical parameter (binding affinity) and a specific physiological outcome (TCR-driven gene activation) — while separately testing whether specificity carries equivalent functional weight.
Why this matters at different levels
For understanding signaling thresholds: TCR signaling output declined proportionally as Gads/SLP-76 affinity weakened, but only down to a threshold KD of approximately 3 µM — below that affinity, no further loss of NFAT activation occurred, identifying a quantitative cutoff below which an SH3-mediated interaction simply ceases to be physiologically relevant to this pathway.
For explaining why a closely related adaptor (Grb2) cannot substitute for Gads: Grb2’s C-SH3 domain binds SLP-76 with only 8 µM affinity — below the ~3 µM functional threshold — explaining at a quantitative level why Grb2, despite sharing a similar domain architecture and being abundantly expressed in T cells, fails to rescue signaling when Gads is absent.
For understanding how cells tolerate molecular promiscuity: An SLP-76 variant (S234P) that bound dozens of additional SH3 domains in vitro signaled just as effectively as wild-type SLP-76 in cells, provided its high-affinity interaction with Gads was preserved — showing that a sufficiently strong primary interaction can effectively buffer against the kind of cross-reactivity that might otherwise corrupt pathway specificity.
The open challenge
Why, then, has the SLP-76 RxxK motif evolved such stringent specificity for Gads if the pathway can tolerate crossreactivity, as long as affinity for Gads remains high? The data raises this question without resolving it: possible explanations include subtler effects of crossreactivity on TCR signaling at physiological (rather than over-expressed) SLP-76 levels, or interference with SH3-dependent processes in other hematopoietic cell types not examined here.
Going forward
Resolving why evolution selected for both high affinity and high specificity — when the data show affinity alone is sufficient for signaling in this assay — will require examining SLP-76 crossreactivity in intact organisms rather than transfected Jurkat cells, where subtle pathway interference or effects in other blood cell lineages might become apparent. More broadly, this affinity-threshold framework offers a template for dissecting other adaptor-mediated signaling nodes, where the same question — does fidelity depend on tight binding, narrow specificity, or both — likely recurs.
